NO984491D0 - SCF-analogpreparater og fremgangsmÕte for fremstilling av disse - Google Patents
SCF-analogpreparater og fremgangsmÕte for fremstilling av disseInfo
- Publication number
- NO984491D0 NO984491D0 NO984491A NO984491A NO984491D0 NO 984491 D0 NO984491 D0 NO 984491D0 NO 984491 A NO984491 A NO 984491A NO 984491 A NO984491 A NO 984491A NO 984491 D0 NO984491 D0 NO 984491D0
- Authority
- NO
- Norway
- Prior art keywords
- methods
- preparation
- analog preparations
- scf analog
- stem cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Diabetes (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/628,428 US5885962A (en) | 1996-04-05 | 1996-04-05 | Stem cell factor analog compositions and method |
PCT/US1997/005541 WO1997038101A1 (en) | 1996-04-05 | 1997-04-03 | Scf analog compositions and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
NO984491D0 true NO984491D0 (no) | 1998-09-25 |
NO984491L NO984491L (no) | 1998-10-05 |
Family
ID=24518837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO984491A NO984491L (no) | 1996-04-05 | 1998-09-25 | SCF-analogpreparater og fremgangsmÕte for fremstilling av disse |
Country Status (17)
Country | Link |
---|---|
US (1) | US5885962A (no) |
EP (1) | EP0904367B1 (no) |
JP (1) | JP4066388B2 (no) |
KR (1) | KR20000004951A (no) |
CN (1) | CN1214734A (no) |
AT (1) | ATE363488T1 (no) |
AU (1) | AU726663B2 (no) |
BR (1) | BR9708578A (no) |
CA (1) | CA2249181C (no) |
CZ (1) | CZ301598A3 (no) |
DE (1) | DE69737766T2 (no) |
ES (1) | ES2286830T3 (no) |
IL (1) | IL126221A0 (no) |
NO (1) | NO984491L (no) |
SK (1) | SK131098A3 (no) |
WO (1) | WO1997038101A1 (no) |
YU (1) | YU41798A (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI0789761T1 (en) * | 1994-11-04 | 2005-10-31 | Applied Research Systems | Human scf, a splice variant thereof, its pharmaceutical use |
US6967092B1 (en) | 1996-10-25 | 2005-11-22 | Mc Kearn John P | Multi-functional chimeric hematopoietic receptor agonists |
US5969105A (en) * | 1996-10-25 | 1999-10-19 | Feng; Yiqing | Stem cell factor receptor agonists |
US6291661B1 (en) | 1998-07-02 | 2001-09-18 | Immunex Corporation | flt3-L mutants and method of use |
PL360914A1 (en) * | 1999-07-15 | 2004-09-20 | Genetics Institute Inc. | Formulations for il-11 |
EP1240196B1 (en) * | 1999-12-23 | 2010-09-08 | Universite De Geneve | Basolateral sorting signal based on scf peptide and inhibitors thereof |
WO2003049693A2 (en) * | 2001-12-06 | 2003-06-19 | Wyeth | Method and composition for inducing weight loss |
US7439063B2 (en) * | 2002-06-11 | 2008-10-21 | Burnham Institute For Medical Research | Neuroprotective synergy of erythropoietin and insulin-like growth factors |
US8911729B2 (en) * | 2011-01-10 | 2014-12-16 | The Regents Of The University Of Michigan | Stem cell factor inhibitor |
US20150018408A1 (en) | 2013-07-10 | 2015-01-15 | The Regents Of The University Of Michigan | Therapeutic antibodies and uses thereof |
WO2014031745A2 (en) * | 2012-08-21 | 2014-02-27 | Nayer Ali | Materials and methods for modulating glucose uptake |
CN105985424B (zh) * | 2015-01-30 | 2019-08-23 | 苏州方舟生物医药有限公司 | 一种干细胞因子功能性肽段及其应用 |
CN105517672B (zh) * | 2015-05-26 | 2019-06-21 | 中国科学院广州生物医药与健康研究院 | 一种人原代细胞培养基及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6936694B1 (en) * | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
WO1991005795A1 (en) * | 1989-10-16 | 1991-05-02 | Amgen Inc. | Stem cell factor |
DE69034258D1 (de) * | 1989-10-16 | 2008-09-18 | Amgen Inc | Stamzellfaktor |
WO1992000376A1 (en) * | 1990-06-25 | 1992-01-09 | Immunex Corporation | Mast cell growth factor |
US20030125519A1 (en) * | 1990-08-27 | 2003-07-03 | Peter Besmer | Ligand for the c-kit receptor and methods of use thereof |
DE4224050A1 (de) * | 1991-07-31 | 1993-02-04 | Hoffmann La Roche | Loesliche kit-liganden |
US5525708A (en) * | 1994-03-28 | 1996-06-11 | Cytomed, Inc. | Covalent dimer of kit ligand |
-
1996
- 1996-04-05 US US08/628,428 patent/US5885962A/en not_active Expired - Fee Related
-
1997
- 1997-04-03 SK SK1310-98A patent/SK131098A3/sk unknown
- 1997-04-03 CA CA002249181A patent/CA2249181C/en not_active Expired - Fee Related
- 1997-04-03 BR BR9708578A patent/BR9708578A/pt unknown
- 1997-04-03 EP EP97917841A patent/EP0904367B1/en not_active Expired - Lifetime
- 1997-04-03 DE DE69737766T patent/DE69737766T2/de not_active Expired - Fee Related
- 1997-04-03 IL IL12622197A patent/IL126221A0/xx unknown
- 1997-04-03 KR KR1019980707544A patent/KR20000004951A/ko not_active Application Discontinuation
- 1997-04-03 JP JP53632097A patent/JP4066388B2/ja not_active Expired - Fee Related
- 1997-04-03 ES ES97917841T patent/ES2286830T3/es not_active Expired - Lifetime
- 1997-04-03 CN CN97193342A patent/CN1214734A/zh active Pending
- 1997-04-03 WO PCT/US1997/005541 patent/WO1997038101A1/en active IP Right Grant
- 1997-04-03 AT AT97917841T patent/ATE363488T1/de not_active IP Right Cessation
- 1997-04-03 CZ CZ983015A patent/CZ301598A3/cs unknown
- 1997-04-03 AU AU26064/97A patent/AU726663B2/en not_active Ceased
-
1998
- 1998-09-24 YU YU41798A patent/YU41798A/sh unknown
- 1998-09-25 NO NO984491A patent/NO984491L/no unknown
Also Published As
Publication number | Publication date |
---|---|
JP4066388B2 (ja) | 2008-03-26 |
AU2606497A (en) | 1997-10-29 |
CZ301598A3 (cs) | 1999-01-13 |
EP0904367B1 (en) | 2007-05-30 |
ES2286830T3 (es) | 2007-12-01 |
CA2249181C (en) | 2009-11-17 |
SK131098A3 (en) | 1999-03-12 |
ATE363488T1 (de) | 2007-06-15 |
KR20000004951A (ko) | 2000-01-25 |
DE69737766D1 (de) | 2007-07-12 |
YU41798A (sh) | 1999-07-28 |
CA2249181A1 (en) | 1997-10-16 |
IL126221A0 (en) | 1999-05-09 |
BR9708578A (pt) | 1999-08-03 |
AU726663B2 (en) | 2000-11-16 |
JP2000508170A (ja) | 2000-07-04 |
CN1214734A (zh) | 1999-04-21 |
US5885962A (en) | 1999-03-23 |
EP0904367A1 (en) | 1999-03-31 |
WO1997038101A1 (en) | 1997-10-16 |
DE69737766T2 (de) | 2007-10-11 |
NO984491L (no) | 1998-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68929043D1 (de) | Für androgen-rezeptor-protein kodierende dna | |
AR006188A1 (es) | "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion". | |
WO2000075350A3 (en) | Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use | |
NO984491L (no) | SCF-analogpreparater og fremgangsmÕte for fremstilling av disse | |
GB9902660D0 (en) | Plant gene | |
HUP0000302A2 (hu) | OB fúziós protein készítmények és módszerek | |
PT101297A (pt) | Factores mitogenicos gliais, sua preparacao e utilizacao | |
DE68927344D1 (de) | Hefezellen der Gattung-Schwanniomyces | |
DK572487A (da) | Fremgangsmaade til fremstilling af human vaekstfaktor fra endotheliale celler | |
DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
DE69939327D1 (de) | Funktionelle antagonisten von hedgehog-aktivität | |
WO2002097038A3 (en) | Chemokine beta-1 fusion proteins | |
GB9722320D0 (en) | Human cell cycle checkpoint proteins | |
EE200000152A (et) | Aminoterminaalselt kärbitud MCP-2 vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon | |
WO1997026322A3 (en) | Methods and compositions for inhibiting hexokinase | |
DK11187D0 (da) | Dna-sekvenser der koder for proteiner med husi-type i inhibitorers biologiske aktivitet, biotekniske fremgangsmaader til fremstilling af proteinerne o g farmaceutiske praeparater der indeholder dem | |
IE871871L (en) | Cloning and expression of acidic fibroblast growth factor | |
LTIP610A (en) | Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds | |
NZ335633A (en) | Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases | |
ES8802441A1 (es) | Procedimiento para preparar laminina humana | |
CA2002833A1 (en) | Interferon-gamma binding proteins | |
ES8801322A1 (es) | Un procedimiento para preparar un material peptidico que tiene actividad humoral timica | |
DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf |